Satagopan JM - Search Results

1

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K. Satagopan JM, et al. Clin Cancer Res. 2002 Dec;8(12):3776-81. Clin Cancer Res. 2002. PMID: 12473589

2

Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract.

Pasche B, Luo Y, Rao PH, Nimer SD, Dmitrovsky E, Caron P, Luzzatto L, Offit K, Cordon-Cardo C, Renault B, Satagopan JM, Murty VV, Massagué J. Pasche B, et al. Among authors: satagopan jm. Cancer Res. 1998 Jul 1;58(13):2727-32. Cancer Res. 1998. PMID: 9661882

3

The APCI1307K allele and breast cancer risk.

Redston M, Nathanson KL, Yuan ZQ, Neuhausen SL, Satagopan J, Wong N, Yang D, Nafa D, Abrahamson J, Ozcelik H, Antin-Ozerkis D, Andrulis I, Daly M, Pinsky L, Schrag D, Gallinger S, Kaback M, King MC, Woodage T, Brody LC, Godwin A, Warner E, Weber B, Foulkes W, Offit K. Redston M, et al. Nat Genet. 1998 Sep;20(1):13-4. doi: 10.1038/1666. Nat Genet. 1998. PMID: 9731522 No abstract available.

4

Association between molecular detection of GAGE and survival in patients with malignant melanoma: a retrospective cohort study.

Cheung IY, Cheung NK, Ghossein RA, Satagopan JM, Bhattacharya S, Coit DG. Cheung IY, et al. Among authors: satagopan jm. Clin Cancer Res. 1999 Aug;5(8):2042-7. Clin Cancer Res. 1999. PMID: 10473084

5

TbetaR-I(6A) is a candidate tumor susceptibility allele.

Pasche B, Kolachana P, Nafa K, Satagopan J, Chen YG, Lo RS, Brener D, Yang D, Kirstein L, Oddoux C, Ostrer H, Vineis P, Varesco L, Jhanwar S, Luzzatto L, Massagué J, Offit K. Pasche B, et al. Cancer Res. 1999 Nov 15;59(22):5678-82. Cancer Res. 1999. PMID: 10582683

6

Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.

Robson M, Levin D, Federici M, Satagopan J, Bogolminy F, Heerdt A, Borgen P, McCormick B, Hudis C, Norton L, Boyd J, Offit K. Robson M, et al. J Natl Cancer Inst. 1999 Dec 15;91(24):2112-7. doi: 10.1093/jnci/91.24.2112. J Natl Cancer Inst. 1999. PMID: 10601383

7

Risk of endometrial carcinoma associated with BRCA mutation.

Levine DA, Lin O, Barakat RR, Robson ME, McDermott D, Cohen L, Satagopan J, Offit K, Boyd J. Levine DA, et al. Gynecol Oncol. 2001 Mar;80(3):395-8. doi: 10.1006/gyno.2000.6082. Gynecol Oncol. 2001. PMID: 11263938

8

The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

Satagopan JM, Offit K, Foulkes W, Robson ME, Wacholder S, Eng CM, Karp SE, Begg CB. Satagopan JM, et al. Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):467-73. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11352856

9

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J, Ellis N, Hensley M, Boyd J, Borgen P, Norton L, Offit K. Scheuer L, et al. J Clin Oncol. 2002 Mar 1;20(5):1260-8. doi: 10.1200/JCO.2002.20.5.1260. J Clin Oncol. 2002. PMID: 11870168

10

Two-stage designs for gene-disease association studies.

Satagopan JM, Verbel DA, Venkatraman ES, Offit KE, Begg CB. Satagopan JM, et al. Biometrics. 2002 Mar;58(1):163-70. doi: 10.1111/j.0006-341x.2002.00163.x. Biometrics. 2002. PMID: 11890312 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page